Complementary and alternative medicine in urologic oncology

The great majority of phytotherapeutic, homeopathic and anthroposophical medicines are subject to the regulations in their respective field of application, implying a simple licensing process. In contrast with conventional medications in the area of oncology, some unconventional agents are given in...

Full description

Saved in:
Bibliographic Details
Published in:Urologe. Ausgabe A Vol. 42; no. 11; p. 1461
Main Authors: Otto, T, Suhr, J, Rübben, H
Format: Journal Article
Language:German
Published: Germany 01.11.2003
Subjects:
Clinical Trials as Topic
Combined Modality Therapy
Complementary Therapies
Humans
Neoplasm Staging
Survival Rate
Treatment Failure
Urologic Neoplasms - mortality
Urologic Neoplasms - pathology
Urologic Neoplasms - therapy
ISSN:0340-2592
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:The great majority of phytotherapeutic, homeopathic and anthroposophical medicines are subject to the regulations in their respective field of application, implying a simple licensing process. In contrast with conventional medications in the area of oncology, some unconventional agents are given in observation studies without the prior testing of quality, side effects and efficacy that is normal in oncology. Unconventional therapeutics cannot be considered equivalent to placebo preparations. Since they may have an immunomodulatory action, one cannot exclude possible long-term adverse effects, including progression of tumors. To date there is no clear indication for routine use of unconventional therapeutic agents in urological oncology. A scientific evaluation according to the criteria of evidence-based medicine is required. This article presents proven results of treatment with unconventional medicines in urooncology against the background of the respective spectrum of methods.
Bibliography:ObjectType-Article-2
SourceType-Scholarly Journals-1
ObjectType-Feature-1
ObjectType-Review-3
content type line 23
ISSN:0340-2592
DOI:10.1007/s00120-003-0458-5